Chugai Pharmaceutical Co Ltd CHGCF:OTCPK

RT Quote | Exchange | USD
Last | 07/29/20 EST
46.25UNCH (UNCH)
52 week range
35.00 - 53.50

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close46.25
  • 52 Week High53.50
  • 52 Week High Date07/06/20
  • 52 Week Low35.00
  • 52 Week Low Date03/06/20
  • Market Cap73,599.72M
  • Shares Out1,643.87M
  • 10 Day Average Volume-
  • Dividend0.52
  • Dividend Yield1.13%
  • Beta0.91
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)1.27
  • P/E (TTM)36.54
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date04/22/2021
  • Ex Div Date06/28/2018
  • Div Amount31.00
  • Split Date-
  • Split Factor-

Latest Chugai Pharmaceutical Co Ltd News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone...
Tatsuro Kosaka
Chairman
Motoo Ueno
Vice Chairman
Osamu Okuda
President
Toshiaki Itagaki
Chief Financial Officer
Shinya Unno
Executive Vice President
Address
15F, Nihonbashi Mitsui Tower
2-1-1, Nihonbashi-Muro-machi
Chuo-ku, TKY
103-8324
Japan